Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Specialties (740)
- Neurology (428)
- Medical Sciences (410)
- Life Sciences (305)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (271)
-
- Neurosciences (194)
- Pathological Conditions, Signs and Symptoms (152)
- Neuroscience and Neurobiology (149)
- Chemicals and Drugs (128)
- Internal Medicine (116)
- Medical Neurobiology (115)
- Diagnosis (108)
- Therapeutics (104)
- Pharmacy and Pharmaceutical Sciences (102)
- Anatomy (98)
- Cardiovascular Diseases (97)
- Rehabilitation and Therapy (90)
- Public Health (88)
- Mental and Social Health (86)
- Psychiatry and Psychology (82)
- Social and Behavioral Sciences (80)
- Molecular and Cellular Neuroscience (76)
- Nervous System (75)
- Immune System Diseases (60)
- Cell and Developmental Biology (56)
- Pediatrics (56)
- Other Pharmacy and Pharmaceutical Sciences (54)
- Institution
-
- University of San Diego (311)
- HCA Healthcare (211)
- Rowan University (149)
- Thomas Jefferson University (111)
- Chapman University (108)
-
- The Texas Medical Center Library (73)
- Aga Khan University (66)
- Philadelphia College of Osteopathic Medicine (56)
- LSU Health New Orleans (55)
- University of Kentucky (48)
- Touro College and University System (39)
- Himmelfarb Health Sciences Library, The George Washington University (35)
- University of Texas Rio Grande Valley (24)
- Virginia Commonwealth University (23)
- University of Tennessee Health Science Center (21)
- City University of New York (CUNY) (19)
- Liberty University (17)
- Marshall University (15)
- Old Dominion University (15)
- Wayne State University (14)
- Children's Mercy Kansas City (13)
- University of Nebraska Medical Center (13)
- Edith Cowan University (12)
- University of Nevada, Las Vegas (12)
- West Virginia University (11)
- Baptist Health South Florida (10)
- Ohio Northern University (10)
- Portland State University (10)
- Roseman University of Health Sciences (10)
- University of Connecticut (10)
- Keyword
-
- Huntington's Disease (313)
- Humans (93)
- Stroke (81)
- Female (60)
- Male (59)
-
- Alzheimer’s disease (51)
- Middle Aged (40)
- Adult (39)
- Neurodegeneration (39)
- Dementia (37)
- Epilepsy (36)
- Parkinson's disease (36)
- Multiple sclerosis (33)
- Alzheimer's disease (31)
- Neuroinflammation (29)
- Aged (27)
- Multiple Sclerosis (27)
- Alzheimer's Disease (25)
- Animals (25)
- Biomarkers (25)
- Inflammation (23)
- Parkinson's Disease (23)
- Alzheimer Disease (22)
- Parkinson’s disease (22)
- Brain (21)
- COVID-19 (21)
- Microglia (20)
- Cognition (19)
- Mice (19)
- Parkinson Disease (19)
- Publication Year
- Publication
-
- At Risk for Huntington's Disease (309)
- Rowan-Virtua Research Day (115)
- Pharmacy Faculty Articles and Research (51)
- School of Medicine Faculty Publications (43)
- PCOM Physician Assistant Studies Student Scholarship (37)
-
- Department of Medicine (27)
- Physical Therapy Faculty Articles and Research (26)
- Department of Neurology Faculty Papers (25)
- Faculty, Staff and Student Publications (25)
- Rowan-Virtua School of Osteopathic Medicine Departmental Research (24)
- Theses and Dissertations (24)
- Dissertations and Theses (Open Access) (23)
- Faculty, Staff and Students Publications (23)
- The Science Journal of the Lander College of Arts and Sciences (21)
- Theses and Dissertations (ETD) (19)
- South Atlantic Division GME Research Days 2026 (17)
- Senior Honors Theses (14)
- East Florida Division GME Research Day 2023 (13)
- Neurology Faculty Publications (13)
- South Atlantic Division GME Research Day 2024 (13)
- Continental and Mountain Divisions GME Resarch Day 2026 (12)
- Research Symposium (12)
- Department of Neurosurgery Faculty Papers (11)
- Graduate Theses, Dissertations, and Problem Reports (ETD) (11)
- Theses & Dissertations (11)
- All Publications (10)
- Annual Research Symposium (10)
- Biology, Chemistry, and Environmental Sciences Faculty Articles and Research (10)
- Dissertations, Theses, and Capstone Projects (10)
- Gulf Coast Division GME Research Day 2026 (10)
- Publication Type
- File Type
Articles 1441 - 1470 of 1882
Full-Text Articles in Nervous System Diseases
Isis Pharmaceuticals Launches Historic Clinical Trial To Silence Huntington's Disease Gene, Kenneth P. Serbin
Isis Pharmaceuticals Launches Historic Clinical Trial To Silence Huntington's Disease Gene, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Multiple Sclerosis And The Implications Of Anesthesia, Timothy B. Maiden
Multiple Sclerosis And The Implications Of Anesthesia, Timothy B. Maiden
Nursing Student Class Projects (Formerly MSN)
Multiple Sclerosis (MS) is an autoimmune process characterized by inflammation and demyelination of axons in the brain and spinal cord (Schneider, 2005). According to Maclean (2010), MS is one of the most common debilitating neurological disorders in young adults. My intent of this research project is to explain the pathophysiological process and become familiar with the implications of anesthesia related to MS. This research will enable me to prepare a safe, individualized anesthetic plan, taking all essential precautions when caring for a patient with multiple sclerosis.
Juvenile Myoclonic Epilepsy, April Britton
Juvenile Myoclonic Epilepsy, April Britton
Nursing Student Class Projects (Formerly MSN)
Juvenile myoclonic epilepsy (JME) is one of the most common epilepsies of childhood (Korff, Nordli, & Eichler, 2014). JME typically occurs in otherwise healthy teenagers, and is characterized by one or more of the following seizure types: myoclonic jerks, generalized tonic clonic seizures, and absence seizures (Korff, Nordli, & Eichler, 2014). JME is thought to have genetically mediated factors (Park, Shahid, & Jammoul, 2015). JME is considered to be gender equal (Korff, Nordli, & Eichler, 2014). Most JME patients are diagnosed between 12 and 18 years of age (Korff, Nordli, & Eichler, 2014). Triggers linked to onset of seizure activity …
Cervical Spinal Cord Injury, Melissa Schimmel
Cervical Spinal Cord Injury, Melissa Schimmel
Nursing Student Class Projects (Formerly MSN)
A spinal cord injury (SCI) can occur at any level of the spinal cord. A SCI involves an interruption between the brain and the body due to an injury or damage to the spinal cord (Sheppard Center, 2011, p1.). The location and extent of the injury is important because it will determine the severity and extent of dysfunction. The higher the injury is to the spinal cord, the more severe the loss of motor function (Sheppard Center, 2011, p.4). The spinal cord injuries are classified by based on the extent of injury, motor and sensory losses. The injury is considered …
Unraveling The Mysteries Of The Mitochondria In Huntington's Disease – And Getting Fast, Clear, And Useful Results From Research Studies, Kenneth P. Serbin
Unraveling The Mysteries Of The Mitochondria In Huntington's Disease – And Getting Fast, Clear, And Useful Results From Research Studies, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Connectivity Measures Are Robust Biomarkers Of Cortical Function And Plasticity After Stroke, Jennifer Wu, Erin Burke Quinlan, Lucy Dodakian, Alison Mckenzie, Nikhita Kathuria, Robert J. Zhou, Renee Augsburger, Jill See, Vu H. Lee, Ramesh Srinivasan, Steven C. Cramer
Connectivity Measures Are Robust Biomarkers Of Cortical Function And Plasticity After Stroke, Jennifer Wu, Erin Burke Quinlan, Lucy Dodakian, Alison Mckenzie, Nikhita Kathuria, Robert J. Zhou, Renee Augsburger, Jill See, Vu H. Lee, Ramesh Srinivasan, Steven C. Cramer
Physical Therapy Faculty Articles and Research
Valid biomarkers of motor system function after stroke could improve clinical decision-making. Electroencephalography-based measures are safe, inexpensive, and accessible in complex medical settings and so are attractive candidates. This study examined specific electroencephalography cortical connectivity measures as biomarkers by assessing their relationship with motor deficits across 28 days of intensive therapy. Resting-state connectivity measures were acquired four times using dense array (256 leads) electroencephalography in 12 hemiparetic patients (7.3 ± 4.0 months post-stroke, age 26–75 years, six male/six female) across 28 days of intensive therapy targeting arm motor deficits. Structural magnetic resonance imaging measured corticospinal tract injury and infarct volume. …
Overcoming The Fear Of The Lion: A Courageous Film About Genetic Testing And Huntington's Disease, Kenneth P. Serbin
Overcoming The Fear Of The Lion: A Courageous Film About Genetic Testing And Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Amyotrophic Lateral Sclerosis, The Primary Motor Neuron Disease, Jacob P. Naumann
Amyotrophic Lateral Sclerosis, The Primary Motor Neuron Disease, Jacob P. Naumann
The Downtown Review: An Interdisciplinary Journal Written and Peer-Reviewed by Mandel Honors College Students at Cleveland State University
Amyotrophic lateral sclerosis is a degenerative neurological disease that damages nerve cells in the brain, in particular the neurons that are involved in voluntary muscle movements. Internationally the disorder is also known as Charcot’s disease and motor neuron disease. In the United States, amyotrophic lateral sclerosis is often referred to as Lou Gehrig’s disease, motor neuron disease, and more colloquially ALS. Amyotrophic Lateral Sclerosis is the most prominent of the five motor neuron diseases, distinguishing itself from the others through degeneration of both upper motor neurons (UMN) and lower motor neurons (LMN) respectively. The “Father of neurology” Jean-Marie Charcot founded …
Novel Advances In Alzheimer's Disease, Jacob P. Naumann
Novel Advances In Alzheimer's Disease, Jacob P. Naumann
The Downtown Review: An Interdisciplinary Journal Written and Peer-Reviewed by Mandel Honors College Students at Cleveland State University
Alzheimer’s disease, the most common form of dementia in adults, is a progressive degenerative neurological disease that affects memory, cognition, and behavior. Dr. Alois Alzheimer discovered and diagnosed the irreversible disease in 1906 after documenting the famous case of Auguste Deter.1 Since the discovery of the disease, numerous advances have made it possible to not only better understand the causal factors, but also to improve the medical diagnosis and preventative measures that healthcare providers can implement. For the first time since 1984, the National Institute on Aging (NIAA) and the Alzheimer’s Association (AA) proposed and published new diagnostic guideline …
The Search For Huntington's Disease Treatments Is Indeed 'Rocket Science' – And We Can All Help Build The Rocket, Kenneth P. Serbin
The Search For Huntington's Disease Treatments Is Indeed 'Rocket Science' – And We Can All Help Build The Rocket, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Deciphering Signals From Huntington’S Disease Brains In The Search For Treatments, Kenneth P. Serbin
Deciphering Signals From Huntington’S Disease Brains In The Search For Treatments, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Age-Dependent Breakdown Of The Blood Brain Barrier And Associated Changes In S100b Ko Mice, Eric V. Brown
Age-Dependent Breakdown Of The Blood Brain Barrier And Associated Changes In S100b Ko Mice, Eric V. Brown
Graduate School of Biomedical Sciences Theses and Dissertations
Autoantibodies play an important role in many autoimmune diseases. Recent research has shown that breakdown of the blood brain barrier (BBB) occurs concomitant to generation of brain reactive autoantibodies in many neurodegenerative diseases, which serve as biomarkers and drivers of pathology. SI00B, a calcium binding protein found most highly expressed in astrocytes which ensheathe the BBB, has many functions in neural development and signaling. Currently literature indicates that S100B KO mice develop normally, with no phenotypic abnormalities. Here, it is demonstrated that S100B KO mice seem to develop a chronic BBB breakdown similar to that seen in human neurodegenerative diseases. …
Alzheimer's Disease: From Clinical Tragedy To Reason For Hope, Kenneth Adams
Alzheimer's Disease: From Clinical Tragedy To Reason For Hope, Kenneth Adams
Bridgewater Review
No abstract provided.
Phenytoin-Induced Purple Glove Syndrome: A Case Report And Review Of The Literature, John Okogbaa, Ifeanyi Onor, Oluwatoyin Arije, Martha Harris, Rebecca Lillis
Phenytoin-Induced Purple Glove Syndrome: A Case Report And Review Of The Literature, John Okogbaa, Ifeanyi Onor, Oluwatoyin Arije, Martha Harris, Rebecca Lillis
Faculty and Staff Publications
OBJECTIVE:To present a case report and literature review of phenytoin-induced purple glove syndrome (PGS).CASE SUMMARY:A 54-year-old African American male presented to our hospital's emergency department (ED) following a seizure episode, cardiac arrest, and loss of consciousness. On arrival to the ED, the patient's total phenytoin level was subtherapeutic at 4.1 mcg/mL and his corrected total phenytoin level was subtherapeutic at 5.1 mcg/mL. In the ED, the patient received a loading dose of intravenous (IV) phenytoin 1,000 mg once via the left cephalic vein, at a rate of 50 mg/min, and was admitted to the medicine service. A day following IV …
Pathological Effects Of Repeated Concussive Tbi In Mouse Models: Periventricular Damage And Ventriculomegaly, Richard H. Wolferz Jr.
Pathological Effects Of Repeated Concussive Tbi In Mouse Models: Periventricular Damage And Ventriculomegaly, Richard H. Wolferz Jr.
Honors Scholar Theses
Repeated concussive traumatic brain injury (rcTBI) is the most prominent form of head injury affecting the brain, with an estimated 1.7 million Americans affected each year (Kuhn 2012). Neurologists have been concerned about the danger of repeated head impacts since the 1920’s, but researchers have only begun to understand the long-term effects of rcTBI (McKee 2009). Although symptoms can be as mild as dizziness, current research suggests that multiple concussions can lead to a progressive degenerative brain disease known as chronic traumatic encephalopathy (CTE) (Luo 2008, McKee 2009, Kane 2013). Research on the brain is just beginning to scratch the …
The Huntington’S Disease Community Can’T Afford To Lose Momentum, Kenneth P. Serbin
The Huntington’S Disease Community Can’T Afford To Lose Momentum, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Barriers To Music Therapy In The Care Of Those With Alzheimer's/Dementia, Karin E. Kvam
Barriers To Music Therapy In The Care Of Those With Alzheimer's/Dementia, Karin E. Kvam
Honors College Theses
This pilot study examines the barriers caregivers encounter when implementing music therapy in the care of those with Alzheimer’s/dementia. An 8-question survey was distributed at two long-term care facilities and an Alzheimer’s support group to understand how often and in what ways music therapy is utilized, as well as what barriers caregivers face when using the therapy. Results indicated that, although the majority of caregivers report using music therapy, it is not implemented as frequently as it could or should be. Caregivers report a knowledge deficit as the main reason for not implementing music therapy. The data suggests that an …
The Plight Of The Lucluc: Examining The Deadly Mystery Of Nodding Syndrome, Ethan K. Mcgann
The Plight Of The Lucluc: Examining The Deadly Mystery Of Nodding Syndrome, Ethan K. Mcgann
Senior Honors Theses
Nodding syndrome (NS) is an emerging epidemic neurological disease that is shrouded in mystery. It is currently only found in the post-conflict regions of South Sudan, northern Uganda, and Tanzania. NS occurs in children from the ages of five to fifteen and is characterized by a loss of motor control in the neck muscles. Seizure episodes can range in intensity from atonic to tonic-clonic, and the onset of the first episode generally marks the beginning of a decline in the child’s physical and mental health. NS is a progressive disease that generally results in physical wasting, stunted growth, behavioral difficulties, …
Engaging A ‘Scared Population’ Of Huntington’S Disease Families By Respecting Their Journeys, Kenneth P. Serbin
Engaging A ‘Scared Population’ Of Huntington’S Disease Families By Respecting Their Journeys, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
The Therapeutic Role Of Turmeric In Treatment And Prevention Of Alzheimer’S Disease, Rylan M. Mcquade
The Therapeutic Role Of Turmeric In Treatment And Prevention Of Alzheimer’S Disease, Rylan M. Mcquade
Selected Honors Theses
As a devastating neurological condition that expends millions of lives each year, Alzheimer’s disease (AD) is a subject of intense investigation.1 Although AD has been known for over a century, the precise mechanisms that underlie AD pathogenesis and development are still poorly understood. The Alzheimer phenotype is typified by extracellular amyloid-beta (Aβ) plaques and intracellular neurofibrillary tangles (NFTs), causing researchers to notice several key enzymes implicated in this process.1 Most notable are β and γ secretases (which drive Aβ plaque production) and phospholipase
A2 (which stimulates major cascade activation through the specific cleavage of fatty acyl esters). …
Implications Of Female Sex On Stroke Risk Factors, Care, Outcome And Rehabilitation: An Asian Perspective, Prachi Mehndiratta, Mohammad Wasay, Man Mohan Mehndiratta
Implications Of Female Sex On Stroke Risk Factors, Care, Outcome And Rehabilitation: An Asian Perspective, Prachi Mehndiratta, Mohammad Wasay, Man Mohan Mehndiratta
Section of Neurology
Background:
Stroke affects 16.9 million people annually and the greatest burden of stroke is in low- and middle-income countries, where 69% of all strokes occur. Stroke risk factors, mortality and outcomes differ in developing countries as compared to the developed world. We performed a literature review of 28 articles pertaining to epidemiology of stroke in Asian women, stroke risk factors, gender-related differences, and stroke outcomes.
Summary:
Asian women differ from women worldwide due to differences in stroke awareness, risk factor profile, stroke subtypes, and social issues that impact stroke care. While Asian men have a higher incidence of stroke as …
The Precious Participation Of The Huntington’S Disease Community In The Quest For Treatments: A Report On The 2015 Hd Therapeutics Conference, Kenneth P. Serbin
The Precious Participation Of The Huntington’S Disease Community In The Quest For Treatments: A Report On The 2015 Hd Therapeutics Conference, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Pharmaceutical Integrated Stress Response Enhancement Protects Oligodendrocytes And Provides A Potential Multiple Sclerosis Therapeutic., Sharon W Way, Joseph R Podojil, Benjamin L Clayton, Anita Zaremba, Tassie L Collins, Rejani B Kunjamma, Andrew P Robinson, Pedro Brugarolas, Robert H. Miller, Stephen D Miller, Brian Popko
Pharmaceutical Integrated Stress Response Enhancement Protects Oligodendrocytes And Provides A Potential Multiple Sclerosis Therapeutic., Sharon W Way, Joseph R Podojil, Benjamin L Clayton, Anita Zaremba, Tassie L Collins, Rejani B Kunjamma, Andrew P Robinson, Pedro Brugarolas, Robert H. Miller, Stephen D Miller, Brian Popko
Anatomy and Regenerative Biology Faculty Publications
Oligodendrocyte death contributes to the pathogenesis of the inflammatory demyelinating disease multiple sclerosis (MS). Nevertheless, current MS therapies are mainly immunomodulatory and have demonstrated limited ability to inhibit MS progression. Protection of oligodendrocytes is therefore a desirable strategy for alleviating disease. Here we demonstrate that enhancement of the integrated stress response using the FDA-approved drug guanabenz increases oligodendrocyte survival in culture and prevents hypomyelination in cerebellar explants in the presence of interferon-γ, a pro-inflammatory cytokine implicated in MS pathogenesis. In vivo, guanabenz treatment protects against oligodendrocyte loss caused by CNS-specific expression of interferon-γ. In a mouse model of MS, experimental …
Guidelines For Pre-Clinical Assessment Of The Acetylcholine Receptor-Specific Passive Transfer Myasthenia Gravis Model - Recommendations For Methods And Experimental Designs., Linda L. Kusner, Mario Losen, Angela Vincent, Jon Lindstrom, Socrates Tzartos, Konstantinos Lazaridis, Pilar Martinez-Martinez
Guidelines For Pre-Clinical Assessment Of The Acetylcholine Receptor-Specific Passive Transfer Myasthenia Gravis Model - Recommendations For Methods And Experimental Designs., Linda L. Kusner, Mario Losen, Angela Vincent, Jon Lindstrom, Socrates Tzartos, Konstantinos Lazaridis, Pilar Martinez-Martinez
Pharmacology and Physiology Faculty Publications
Antibodies against the muscle acetylcholine receptor (AChR) are the most common cause of myasthenia gravis (MG). Passive transfer of AChR antibodies from MG patients into animals reproduces key features of human disease, including antigenic modulation of the AChR, complement-mediated damage of the neuromuscular junction, and muscle weakness. Similarly, AChR antibodies generated by active immunization in experimental autoimmune MG models can subsequently be passively transferred to other animals and induce weakness. The passive transfer model is useful to test therapeutic strategies aimed at the effector mechanism of the autoantibodies. Here we summarize published and unpublished experience using the AChR passive transfer …
Brain Blast 2015 Speakers Poster, Annie Leslie
Brain Blast 2015 Speakers Poster, Annie Leslie
Brain Blast
Poster from UNE's Brain Blast 2015 listing the expected presenters at this event.*
‘None Of Us Are Free Until We Are All Free’: Science And Solidarity At The 10th Annual Huntington's Disease Therapeutic Conference, Kenneth P. Serbin
‘None Of Us Are Free Until We Are All Free’: Science And Solidarity At The 10th Annual Huntington's Disease Therapeutic Conference, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
‘Darkness Replaced By Hope And Light’: Taking Stock Of Huntington's Disease Research, Kenneth P. Serbin
‘Darkness Replaced By Hope And Light’: Taking Stock Of Huntington's Disease Research, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Huntington’S Disease Patients ‘Feel Better’ After Takin Auspex Compound To Control Chorea In Clinical Trial, Kenneth P. Serbin
Huntington’S Disease Patients ‘Feel Better’ After Takin Auspex Compound To Control Chorea In Clinical Trial, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Fighting – And Writing – To Stay Healthy: Ten Years Of 'At Risk For Huntington's Disease', Kenneth P. Serbin
Fighting – And Writing – To Stay Healthy: Ten Years Of 'At Risk For Huntington's Disease', Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Assessment Of Three Acute Responses To Traumatic Brain Injury, Shoshana Fireworker
Assessment Of Three Acute Responses To Traumatic Brain Injury, Shoshana Fireworker
The Science Journal of the Lander College of Arts and Sciences
Traumatic brain injury has a devastating effect on millions worldwide each year. As yet, there are no methods which have been proven to improve recovery from the trauma. Current treatment protocols revolve around reducing secondary insult, such as hypoxia, hypotension, and cerebral edema, which raises intracranial pressure. The purpose of this study is to assess the efficacy of three responses to traumatic brain injury. Two of them, the administration of hypertonic saline and the administration of progesterone, are pharmacologic, while the third, the performance of a decompressive craniectomy, is surgically invasive. A number of original studies have been analyzed to …